Home Compounds Ipamorelin
Synthetic pentapeptide GH secretagogue WADA prohibited Investigational

Ipamorelin.

Also known as: NNC 26-0161

The cleanest growth hormone secretagogue — a GH pulse without the cortisol, prolactin, or appetite spike of its predecessors.

EP
Researched and edited by the Epti editorial team
Every claim labeled by confidence tier · reviewed quarterly · last updated May 20, 2026
01 · Quick overview

The TL;DR.

What it is
A synthetic pentapeptide GH secretagogue that mimics ghrelin to stimulate endogenous growth hormone — highly selective, with no significant cortisol or prolactin elevation.
Half-life
~2 hours emerging — supports daily or 2×/day dosing
Typical dose
100–300 mcg daily, subcutaneous community
Status
Investigational. WADA-prohibited. Not FDA-approved.
Who it's for
Anti-aging benefits, improved sleep, enhanced recovery — without the side effects of exogenous HGH or less selective secretagogues.
Biggest risk
Long-term GHSR-1a agonism is uncharacterized in humans. Sustained GH elevation can theoretically decrease insulin sensitivity over time.

Ipamorelin is a highly selective growth hormone secretagogue. Unlike earlier peptides in its class — GHRP-2 or GHRP-6 — it stimulates a robust pulse of growth hormone without causing a concurrent spike in cortisol (the stress hormone) or prolactin well-established.[2] It also does not induce the intense hunger typically associated with ghrelin mimetics.

Because of this "clean" side-effect profile, it is widely considered the safest and most tolerable peptide for long-term growth hormone elevation in the anti-aging and biohacking communities. However, human clinical data remains limited. It was investigated for postoperative ileus but the program was halted after a failed Phase 2 trial.[3]

02 · Protocol & usage guide

How it's actually used.

Important
Ipamorelin is an investigational compound. The protocols below reflect community consensus and observational data, not medical advice.

Before you start

  • Identify the goal. Ipamorelin is typically used for anti-aging, sleep improvement, and slow, steady body composition changes. It is not a rapid muscle builder.
  • Understand the regulatory status. Ipamorelin cannot be legally prescribed or compounded in the US.
  • Check your sport's rules. Ipamorelin is prohibited by WADA and most major sporting organizations.
  • Fasting requirement. Ipamorelin must be injected on an empty stomach (at least 2 hours after eating) because insulin blunts the growth hormone pulse. well-established[4]

Standard community dosing

LevelDoseFrequency & routeCycle
Beginner100 mcg1× daily (before bed) · subcutaneous8–12 wk
Intermediate200 mcg1× daily (before bed) · subcutaneous12–16 wk
Advanced300 mcg2× daily (AM + bed) · subcutaneous12–16 wk

Doses above 300 mcg per injection do not significantly increase the GH pulse due to pituitary saturation (the "ceiling effect"). community

Reconstitution math (injectable)

Ipamorelin typically arrives as a lyophilized powder in a 2 mg or 5 mg vial. It must be reconstituted with bacteriostatic water.

For a 2 mg vial · target 100–200 mcg per dose

  1. Add 2 mL of bacteriostatic water to the vial.
  2. Final concentration: 1 mg/mL (1,000 mcg/mL).
  3. For a 100 mcg dose: pull to the "10" mark on a 1 mL (100-unit) insulin syringe ≈ 0.1 mL.
  4. For a 200 mcg dose: pull to the "20" mark ≈ 0.2 mL.

Injection site selection

  • Community consensus: subcutaneous injection into abdominal fat is the standard approach. community
Safety note
Ensure proper sterile technique. Rotate injection sites to prevent lipohypertrophy.

Missed doses

  • Missed 1 day: take the normal dose the next day. Do not double-dose.
  • Missed 3+ days: resume the normal protocol.

Community consensus and real-world experience

In community discussions, Ipamorelin is most frequently praised for its positive impact on sleep architecture (specifically deep sleep) and skin elasticity. Users often report feeling more rested and recovering faster from workouts. community[11] Unlike GHRP-6, users rarely report intense hunger.[12]

epti
Track your protocol

Log Ipamorelin injections, IGF-1 trends, and sleep on one timeline.

Anti-aging protocols only work if you can see trends over months. Epti correlates your nightly injection with sleep quality, training load, and quarterly IGF-1 draws.

Join waitlist →
03 · Nutritional support & supplements

What to eat alongside.

Macronutrient adjustments

  • Carbohydrates — must be strictly managed around the injection window. Do not consume carbohydrates for at least 2 hours before and 30 minutes after injection, as insulin blunts the GH release.[4]

Micronutrient adjustments

No data available — Ipamorelin does not have specific micronutrient dependencies beyond general health requirements.

Synergistic supplements

  • Melatonin — 0.5–1 mg, 30 min before bed. Deepens slow-wave sleep, amplifying the natural nocturnal GH pulse that Ipamorelin enhances.
  • Magnesium glycinate — 200–400 mg at bedtime. Supports sleep quality and GH secretion.

Protective supplements

No data available — Ipamorelin has no known organ toxicity requiring specific protective supplements based on current data.

04 · Safety, interactions & side-effects

What can go wrong.

Critical
The safety profile of Ipamorelin in humans is based on very limited clinical trials. Long-term risks of sustained GHSR-1a agonism are unknown.

Reported side effects

EffectFrequencySeverityManagement
Injection-site reaction Occasional community Sterile technique; rotate sites
Head rush / flushing Occasional community Normal physiological response to GH pulse
Water retention Rare community Monitor sodium intake; usually subsides

Drug interactions

No formally documented drug interactions. It should not be combined with exogenous insulin around the injection window — insulin will negate Ipamorelin's effects.

Contraindications

Absolute
  • Active cancer or history of cancer — elevated IGF-1 provides a pro-growth environment for tumors
Relative
  • Pre-existing insulin resistance or diabetes — elevated GH can temporarily decrease insulin sensitivity

Red flags

Stop immediately if
  • Rapid, unexplained swelling or heat at the injection site (signs of infection)
  • Severe allergic reaction — hives, difficulty breathing
  • Significant, sustained increases in fasting blood glucose

Pregnancy, lactation & fertility

No data available — Ipamorelin has not been studied in pregnant or lactating women, nor has its effect on human fertility been evaluated. It should be strictly avoided in these populations.

Theoretical risks

  • Insulin resistance. While less severe than MK-677, sustained elevation of growth hormone can theoretically decrease insulin sensitivity over time.
  • Tumor growth. Elevated IGF-1 levels theoretically provide a pro-growth environment for existing malignancies.
05 · Stacks & combinations

What to combine it with.

Stack 1 · the classic anti-aging stack

Ipamorelin + CJC-1295 (No DAC)

Ipamorelin 100–200 mcg CJC-1295 No DAC 100 mcg 1–2×/day · combined syringe

The most common GH-axis stack. Ipamorelin stimulates GH via the ghrelin receptor; CJC-1295 (a GHRH mimetic) amplifies the pulse via the GHRH receptor. They work synergistically — not additively — to produce a much larger GH release than either alone. community[13]

Stack 2 · visceral fat targeting

Ipamorelin + Tesamorelin

Ipamorelin 100–200 mcg Tesamorelin 1 mg Before bed

Tesamorelin is an FDA-approved GHRH analogue shown to reduce visceral adipose tissue. Stacking with Ipamorelin provides synergistic GH elevation while targeting stubborn belly fat. community

Anti-pattern stacks — avoid

Moderate
  • Ipamorelin + MK-677. Both compete for the same GHSR-1a receptor. Stacking provides no additional benefit and increases receptor desensitization + insulin resistance risk.
High
  • Ipamorelin + exogenous HGH. Exogenous HGH suppresses natural pituitary function, rendering secretagogues like Ipamorelin completely ineffective.
06 · Body composition & training

How to train on it.

Ipamorelin is a slow-acting compound. It does not produce rapid changes in body weight or muscle mass.

Expected trajectory

Weeks 1–2Improved sleep quality, vivid dreams, slight water retention.
Weeks 3–6Improved skin elasticity, faster recovery from workouts.
Weeks 8–12+Gradual improvements in body composition — modest fat loss, lean mass retention.

Training adjustments

  • No specific training adjustments are required. It supports recovery from standard resistance training and cardiovascular protocols.

Cut / recomp / bulk contexts

  • Cut: Excellent for preserving lean muscle mass during a caloric deficit.
  • Recomp: Supports slow, steady recomposition over several months.
  • Bulk: Less effective than MK-677 for bulking — does not stimulate appetite.
07 · Storage, handling & accessibility

How to store it.

Pre-reconstitution · lyophilized powder
-20 °C

Long-term freezer storage, up to 24 months. Tolerable at room temperature for several weeks during shipping.

Post-reconstitution · solution
2–8 °C

Refrigerate. Beyond-use date: 28 days. Discard if cloudy or particulate-containing.

Light & freeze sensitivity

  • Light — keep vials away from direct sunlight.
  • Freeze — do not freeze the reconstituted solution.

Sourcing & legal access

  • United States. Investigational new drug. Not approved for human use. Cannot be legally compounded.
  • Cost-per-cycle (USD). Typically $50–$100 per month via research-chemical vendors.
  • Global. Not approved as a human therapeutic in any major jurisdiction.
08 · Bloodwork monitoring

What to track.

While Ipamorelin is considered mild, monitoring the GH / IGF-1 axis and insulin sensitivity is recommended.

Baseline panel

MarkerWhy it mattersRed flag
IGF-1Establishes baseline to measure efficacy.
Fasting glucose & HbA1cEnsures baseline insulin sensitivity is healthy.FG > 100 mg/dL

Mid-cycle panel

MarkerWhy it mattersRed flag
IGF-1Confirms the compound is active and elevating levels.Above high-normal range
Fasting glucoseMonitors for GH-induced insulin resistance.FG > 100 mg/dL

Post-cycle panel

MarkerWhy it mattersRed flag
Fasting glucose & HbA1cEnsures insulin sensitivity has returned to baseline.Sustained elevation

Doctor handoff

Print this. Hand it to your physician.
Patient is utilizing Ipamorelin, an investigational growth hormone secretagogue, for anti-aging and recovery purposes. The compound stimulates endogenous GH release. Please monitor IGF-1 to assess efficacy and fasting glucose / HbA1c to ensure glycemic control remains stable.
09 · Comparison

vs. similar compounds.

IpamorelinGHRP-2MK-677CJC-1295 (No DAC)
ClassGHRP (ghrelin mimetic)GHRP (ghrelin mimetic)Oral GHSR agonistGHRH mimetic
SelectivityHigh — no cortisol/prolactinLow — raises cortisol/prolactinLowHigh
AppetiteNoneModerateExtremeNone
RouteSCSCOralSC
Half-life~2 hours~30 min~24 hours~30 min

When to pick Ipamorelin

Choose Ipamorelin for a clean, side-effect-free GH pulse — especially for anti-aging and sleep improvement.

When to pick GHRP-2

Choose GHRP-2 if a stronger GH pulse is needed and slight appetite stimulation/cortisol elevation is acceptable.

When to pick MK-677

Choose MK-677 only if oral administration is mandatory or extreme appetite stimulation is desired for bulking.

When to pick CJC-1295

Choose CJC-1295 to stack with Ipamorelin to amplify the GH pulse via the GHRH pathway.

10 · Deep dive

What the mechanism looks like.

Mechanism of action

Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that acts as a selective agonist of the GHSR-1a. Upon binding receptors in the pituitary gland, it stimulates a dose-dependent release of growth hormone.[2]

Crucially, Ipamorelin was designed to be highly selective. Unlike GHRP-2 and GHRP-6, which also stimulate the release of ACTH (leading to cortisol) and prolactin, Ipamorelin does not significantly elevate these hormones even at high doses.[2]

Pharmacokinetics

In humans, Ipamorelin has a terminal half-life of approximately 2 hours following intravenous administration.[1] It is rapidly cleared, which mimics the natural pulsatile release of growth hormone rather than causing a sustained, unnatural elevation.

Active metabolites

No data available — specific metabolic breakdown pathways in humans are not fully characterized.

Human clinical trials

Ipamorelin has very limited human clinical data. It was investigated for postoperative ileus but development was halted.

StudynDurationPopulationResult
Gobburu et al. (1999)6Single doseHealthy malesEstablished 2-h half-life, dose-dependent GH release. IV route. Phase 1.
Beck et al. (2014)1147–14 daysBowel-resection patientsFailed to reduce time to first bowel movement. Development halted.

Key animal studies

StudyModelEndpointResult
Raun et al. (1998)Swine / ratsGH, cortisol, prolactinHigh selectivity for GH release without cortisol/prolactin spikes
Johansen et al. (1999)RatsBone growthStimulated longitudinal bone growth and body weight gain

Open questions

  • What is the exact subcutaneous bioavailability in humans?
  • Does long-term daily use lead to receptor downregulation or pituitary fatigue?
11 · FAQ

Frequently asked.

Does Ipamorelin build muscle?

Not directly or rapidly. It increases growth hormone, which aids in recovery and lean mass preservation, but it is not a strong anabolic agent like testosterone.

Ipamorelin vs Sermorelin: which is better?

Ipamorelin is a ghrelin mimetic; Sermorelin is a GHRH mimetic. They work on different pathways. Ipamorelin has a longer half-life (~2 hours vs. 10–20 minutes for sermorelin). Most practitioners stack a GHRP like Ipamorelin with a GHRH like CJC-1295 rather than picking one.

Does Ipamorelin cause weight gain?

It can cause slight, temporary water retention in the first few weeks, but it does not cause fat gain. It is often used to support fat loss.

How long does it take Ipamorelin to work?

Improvements in sleep are often noticed within the first week. Changes in skin elasticity and body composition take 8 to 12 weeks of consistent use.

Is Ipamorelin safe?

It is considered one of the safest GH secretagogues due to its high selectivity — no cortisol/prolactin spikes — but long-term human safety data is lacking.

Can I take Ipamorelin orally?

No. Ipamorelin is a peptide and will be destroyed by stomach acid. It must be injected subcutaneously.

Will Ipamorelin shut down my natural GH production?

No. As a secretagogue, it stimulates your pituitary to produce more of its own GH. It does not suppress natural production like exogenous HGH does.

12 · Regulatory & legal status

Where it stands, by jurisdiction.

Last verified · May 17, 2026

AgencyStatusDetails
US FDAUnapprovedInvestigational new drug. Not approved for human use.
US DEANot scheduledNot a controlled substance.
UK MHRAUnapprovedNot licensed as a medicine.
EU EMAUnapprovedNot authorized for medical use.
Health CanadaUnapprovedNot authorized for sale.
Australia TGAUnapprovedNot entered on the ARTG.
WADABannedProhibited under S2 (Peptide Hormones, Growth Factors).
NCAABannedFollows WADA guidelines.
NFL, MLB, NBABannedClassified as a performance-enhancing substance.
13 · Decision tree

Is Ipamorelin for you?

Are you a drug-tested athlete?
Yes
STOP — Ipamorelin is banned by WADA
No → What's your primary goal?
Rapid muscle growth
STOP — Ipamorelin is not highly anabolic
Appetite stimulation
Consider MK-677 instead
Anti-aging, sleep, recovery → Willing to inject daily?
No
Consider oral alternatives (with higher side effects)
Yes
Ipamorelin is the community standard for clean GH elevation
Q1. Are you subject to anti-doping testing?
If yes, stop. Ipamorelin is banned by WADA and will result in a doping violation.
Q2. Are you looking for rapid muscle growth?
If yes, stop. Ipamorelin is a slow-acting anti-aging and recovery compound, not a strong anabolic agent.
Q3. Are you looking for extreme appetite stimulation for bulking?
If yes, consider MK-677. Ipamorelin does not stimulate appetite.
Q4. Are you seeking anti-aging, sleep, and recovery — and willing to inject daily?
If yes, Ipamorelin is widely considered the safest and most selective option in the peptide community.
14 · References

What we cited.

  1. Gobburu J.V. et al. (1999). Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharm Res. 16(9):1412–1416. PMID: 10496658.
  2. Raun K. et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 139(5):552–561. PMID: 9849822.
  3. Beck D.E. et al. (2014). Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for postoperative ileus in bowel-resection patients. Int J Colorectal Dis. 29(12):1527–1534. PMID: 25331030.
  4. Maccario M. et al. (1995). The GH-releasing effect of hexarelin in normal and obese subjects and its interaction with GHRH or arginine. Eur J Endocrinol. 133(4):399–404.
  5. Johansen P.B. et al. (1999). Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Horm IGF Res. 10(1):14–21.
  6. Reddit r/Peptides. "Ipamorelin dosing protocol." Accessed May 17, 2026.
  7. Reddit r/Peptides. "Ipamorelin without appetite increase?" Accessed May 17, 2026.
  8. Reddit r/Peptides. "Stacking MK-677 w/ Ipamorelin/CJC-1295 combo?" Accessed May 17, 2026.

Track your protocol.

Epti is the first training app built around your peptide protocol — workouts, dosing, side effects, and bloodwork that actually talk to each other.